Evidence map›Paper›PMID 39720653›Full record

ArticleFrontiers in medicine2024

Case report: Atypical POEMS syndrome without polyneuropathy, complicated by borderline TAFRO syndrome.

Shuai Tan, Mingyue Shang, Yasufumi Masaki, Jing Ni, Yuwei Da, Jing Sun, Yaofang Cao, Li Su, Wanling Sun

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. POEMS syndrome presenting withFrontiers in medicine · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shuai Tan *Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Mingyue Shang *Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Yasufumi MasakiHematology and Immunology, Kanazawa Medicai University, Uchinada, Japan.
Jing NiDepartment of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Yuwei DaDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Jing SunDepartment of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Yaofang CaoDepartment of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Li SuDepartment of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Wanling SunDepartment of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

POEMS syndrome is a complex and rare hematological disease involving multiple physiological systems. According to the currently accepted diagnostic criteria for POEMS syndrome, polyneuropathy is one of the primary mandatory criteria. A patient presented with M protein, Castleman disease (CD), elevated vascular endothelial growth factor (VEGF), extravascular volume overload, and endocrinopathy. However, edema of the extremities hindered the diagnosis of polyneuropathy by electromyography (EMG). Eventually, we diagnosed the patient with atypical POEMS syndrome without polyneuropathy. The case also exhibited features consistent with TAFRO syndrome, such as anasarca, thrombocytopenia, and renal insufficiency. This underscores the need to emphasize that TAFRO syndrome is principally a systemic inflammatory disorder. Timely diagnosis and treatment with dexamethasone, followed by several sessions of lenalidomide and dexamethasone (Rd) regimen chemotherapy, resulted in complete remission (CR), and was followed by autologous stem cell transplantation (ASCT). This case offers valuable insights into the diagnosis and treatment of POEMS syndrome, which may prompt a reconsideration of the diagnostic criteria for this syndrome.

Indexed as

ASCTCastleman diseaseperipheral neuropathyPOEMS syndromeTAFRO syndrome

Identifiers

PMID39720653
PMCPMC11666388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.